Enterprise Opthalmics Profile
Key Indicators
- Authorised Capital ₹ 3.01 Cr
- Paid Up Capital ₹ 3.01 Cr
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Dec 2023
- Revenue Growth 50.83%
- Profit Growth -27.42%
- Ebitda -28.57%
- Net Worth 19.96%
- Total Assets 20.78%
About Enterprise Opthalmics
Enterprise Opthalmics Private Limited (EOPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 February 2011 and has a history of 13 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 3.01 Cr and a paid-up capital of Rs 3.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kanishka Aggarwal, Ashok Nathan, Milind Jadhav, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2011PTC213596
-
Company No.
213596
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Feb 2011
-
Date of AGM
14 Jun 2024
-
Date of Balance Sheet
31 Dec 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Enterprise Opthalmics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanishka Aggarwal
|
Director | 19-Nov-2012 | Current |
|
Ashok Nathan
|
Director | 27-Sep-2019 | Current |
|
Milind Jadhav
|
Director | 13-Apr-2023 | Current |
|
Ashutosh Aggarwal
|
Director | 25-Apr-2011 | Current |
Financial Performance of Enterprise Opthalmics.
Enterprise Opthalmics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.83% increase. The company also saw a substantial fall in profitability, with a 27.42% decrease in profit. The company's net worth Soared by an impressive increase of 19.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enterprise Opthalmics?
Unlock access to Enterprise Opthalmics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gkb Optic Technologies Private LimitedAshok Nathan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enterprise Opthalmics?
Unlock and access historical data on people associated with Enterprise Opthalmics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enterprise Opthalmics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enterprise Opthalmics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
